IMRX

IMRX

USD

Immuneering Corporation Class A Common Stock

$6.380+0.170 (2.738%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$6.210

高値

$6.730

安値

$6.150

出来高

0.05M

企業ファンダメンタルズ

時価総額

403.5M

業種

バイオテクノロジー

United States

取引統計

平均出来高

1.87M

取引所

NGM

通貨

USD

52週レンジ

安値 $1.1現在値 $6.380高値 $10.08

関連ニュース

GlobeNewswire

Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025

- New case studies on first-line pancreatic cancer patients treated with atebimetinib in combination with FOLFIRINOX to be shared by trial investigators – - Conference call scheduled for Wednesday, November 12, 2025, at

もっと見る
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
Analyst Upgrades

Leerink Partners Initiates Coverage On Immuneering with Outperform Rating, Announces Price Target of $15

Leerink Partners analyst Andrew Berens initiates coverage on Immuneering with a Outperform rating and announces Price Target of $15.

もっと見る
Leerink Partners Initiates Coverage On Immuneering with Outperform Rating, Announces Price Target of $15